Abstract
Purpose
To obtain performance values of PET/CT for determining the nodal status of rectal cancer.
Materials
A comprehensive literature search was performed on PubMed and Embase for original diagnostic accuracy studies on the diagnostic performance of PET-CT for detection of LN metastasis in rectal cancer. The QUADAS-2 was used to evaluate the methodological quality of each study. Pooled sensitivity, specificity, and AUC were calculated to estimate the diagnostic role of PET/CT using a random-effects model. A subgroup analysis was performed to investigate the influence of different parameters on diagnostic performance.
Results
A total of 15 studies and 1209 patients were included. A publication bias was observed. The pooled sensitivity, specificity, and AUC for PET/CT was 0.62 (95% CI 0.49, 0.74), 0.94 (95% CI 0.87, 0.97), and 0.87 (95% CI 0.83–0.89), respectively. Per-node basis yields higher accuracy than per-patient basis, with pooled sensitivities of 0.65 (95% CI 0.50–0.79) vs. 0.56 (95% CI 0.36–0.77) and specificities of 0.96 (95% CI 0.92–1.00) vs. 0.88 (95% CI 0.76–1.00), but there were no significant differences in diagnostic accuracy.
Conclusion
PET/CT has high specificity but moderate sensitivity for the detection of LN metastasis in rectal cancer. The current data suggests that the diagnostic capabilities of this method is limited due to its moderate sensitivity.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00261-023-04140-4/MediaObjects/261_2023_4140_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00261-023-04140-4/MediaObjects/261_2023_4140_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00261-023-04140-4/MediaObjects/261_2023_4140_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00261-023-04140-4/MediaObjects/261_2023_4140_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00261-023-04140-4/MediaObjects/261_2023_4140_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00261-023-04140-4/MediaObjects/261_2023_4140_Fig6_HTML.png)
Similar content being viewed by others
Abbreviations
- LN:
-
Lymph node
- MRI:
-
Magnetic resonance imaging
- CT:
-
Computed tomography
- EUS:
-
Endoscopic ultrasonography
- TP:
-
True positives
- TN:
-
True negatives
- FN:
-
False negatives
- FP:
-
False positives
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61 (2): 69-90.
Hotta M, Minamimoto R, Yano H, Gohda Y, Shuno Y. Diagnostic performance of (18)F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRI. Cancer imaging. 2018; 18 (1): 4.
Pahk K, Rhee S, Kim S, Choe J G. Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer. PloS one. 2016; 11 (2): e0148776.
Lee JH, Lee MR. Positron emission tomography/computed tomography in the staging of colon cancer. Ann Coloproctol. 2014;30 (1):23-7.
Kwak JY, Kim JS, Kim HJ, Ha HK, Yu CS, Kim JC. Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer. World J Surg. 2012; 36 (8): 1898-905.
Li XT, Sun YS, Tang L, Cao K, Zhang XY. Evaluating local lymph node metastasis with magnetic resonance imaging, endoluminal ultrasound and computed tomography in rectal cancer: a meta-analysis. Colorectal Dis. 2015; 17 (6): O129-35.
Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology. 2004; 232 (3): 773-83.
Yukimoto R, Uemura M, Tsuboyama T, Hata T, Fujino S, Ogino T, et al, Efficacy of positron emission tomography in diagnosis of lateral lymph node metastases in patients with rectal Cancer: a retrospective study. BMC Cancer. 2021; 21 (1): 520.
Park IJ, Kim HC, Yu CS, Ryu MH, Chang HM, Kim JH, et al, Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol. 2006; 32 (9): 941-7.
Erturk SM, Ichikawa T, Fujii H, Yasuda S, Ros PR, PET imaging for evaluation of metastatic colorectal cancer of the liver. Eur J Radiol. 2006; 58 (2): 229-35.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma J B, et al, QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155 (8): 529-36.
Paardt M P, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology. 2013; 269 (1): 101-12.
Hu J. Zhang K, Yan Y, Zang Y, Wang Y, Xue F. Diagnostic accuracy of preoperative (18)F-FDG PET or PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta-analysis. Arch Gynecol Obstet. 2019; 300 (3): 519-529.
Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake--the role of PET/CT. Eur Radiol. 2006; 16 (5): 1054-65.
Roberts PF, Follette DM, von Haag D, Park JA, Valk PE, Pounds T R, et al, Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg. 2000; 70 (4): 1154-9.
Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN,et al, Diffusion-weighted MR imaging in comparison to integrated [18F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol. 2012; 81 (1): 178-82.
Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol. 2008; 38 (5): 347-53.
Zhang YC, Li M, Jin YM, Xu JX, Huang CC, Song B. Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer. World J Gastroenterol.2022;28 (29): 3960-3970.
Kim S J, Lee SW. Diagnostic accuracy of (F)18 flucholine PET/CT for preoperative lymph node staging in newly diagnosed prostate cancer patients; a systematic review and meta-analysis. Br J Radiol. 2019; 92 (1101): 20190193.
Shen G, Lan Y, Zhang K, Ren P, Jia Z.Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis. PloS one. 2017; 12 (3): e0173104.
Lee DH, Lee JM.Whole-body PET/MRI for colorectal cancer staging: Is it the way forward? J Magn Reson Imaging. 2017; 45 (1): 21-35.
Kunawudhi A, Sereeborwornthanasak K, Promteangtrong C, Siripongpreeda B, Vanprom S, Chotipanich C. Value of FDG PET/Contrast-Enhanced CT in Initial Staging of Colorectal Cancer - Comparison with Contrast- Enhanced CT. Asian Pac J Cancer Prev. 2016; 17 (8): 4071-4075.
Amano K, Fukuchi M, Kumamoto K, Hatano S, Ohno H, Osada H, et al. Pre-operative Evaluation of Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer: Comparison of Three Different Imaging Modalities. J Anus Rectum Colon 2020; 4 (1): 34-40.
Nakai N, Yamaguchi T, Kinugasa Y, Shiomi A, Kagawa H, Yamakawa Y, et al. Diagnostic value of computed tomography (CT) and positron emission tomography (PET) for paraaortic lymph node metastasis from left-sided colon and rectal cancer. Asian J Surg. 2020; 43 (6): 676-682.
Li F, Hu J, Jiang H, Sun Y. Diagnosis of lymph node metastasis on rectal cancer by PET-CT computer imaging combined with MRI technology. J Infect Public Health. 2020; 13 (9): 1347-1353.
Todate Y, Honda M, Takada T, Saginoya T, Yamaguchi H, Hamada K, et al. The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis. J Surg Oncol. 2021; 124 (7): 1085-1090.
He J, Wang Q, Zhang Y, Wu H, Zhou Y, Zhao S. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on (18)F-FDG PET/CT and machine learning. Ann Nucl Med. 2021; 35 (5): 617–627.
Seto S, Tsujikawa T, Sawai K, Kurebayashi H, Morikawa M, Okazawa H, et al. Feasibility of [18F] FDG PET/MRI with Early-Delayed and Extended PET as One-Stop Imaging for Staging and Predicting Metastasis in Rectal Cancer. Oncology. 2022; 100 (4): 212–220.
Funding
This work was supported by Medical and Health Science and Technology Plan Project of Zhejiang Province (Grant Number: 2022KY1296). The funding departments had no role in the collection, analysis, or interpretation of the data, or in the decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ma, W., Chen, B., Zhu, F. et al. Diagnostic role of F-18 FDG PET/CT in determining preoperative Lymph node status of patients with rectal cancer: a meta-analysis. Abdom Radiol (2024). https://doi.org/10.1007/s00261-023-04140-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00261-023-04140-4